Skip to main content
Erschienen in: Medical Microbiology and Immunology 1/2019

06.08.2018 | Original Investigation

Chylous ascites, anti-interferon-gamma autoantibody, and angioimmunoblastic T-cell lymphoma: a rare but intriguing connection over Mycobacterium avium

verfasst von: Yusuke Koizumi, Takuro Sakagami, Hitoshi Minamiguchi, Aya Makino, Ami Aoki, Keiko Hodohara, Hiroshige Mikamo, Akira Andoh, Yoshihide Fujiyama

Erschienen in: Medical Microbiology and Immunology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

We report a case of non-AIDS (acquired immunodeficiency syndrome), non-CAPD (Continuous Ambulatory Peritoneal Dialysis), non-cirrhotic, Mycobacterium avium peritonitis, which is a rare form of mycobacterial infection. A 66-year-old Japanese man who had been treated previously for angioimmunoblastic T-cell lymphoma (AITL), had developed disseminated M. avium infection. Antimycobacterial regimen improved his symptoms; however, following an interruption in treatment, he developed chylous ascites. The patient died of uncontrolled peritonitis despite intensive treatment. Anti-interferon-γ autoantibody was positive, and AITL was presumed to be involved in autoantibody production. A rare coexistence of chylous ascites, autoantibody, and AITL taught us an intriguing lesson on the pathogenesis of M. avium infection. Particularly, we conclude that treatment strategies for M. avium infection should aim to restore immunity.
Literatur
1.
Zurück zum Zitat Press OW, Press NO, Kaufman SD (1982) Evaluation and management of chylous ascites. Ann Intern Med 96:358–364CrossRefPubMed Press OW, Press NO, Kaufman SD (1982) Evaluation and management of chylous ascites. Ann Intern Med 96:358–364CrossRefPubMed
2.
Zurück zum Zitat Steinemann DC, Dindo D, Clavien PA, Nocito A (2011) Atraumatic chylous ascites: systematic review on symptoms and causes. J Am Coll Surg 212:899–905CrossRefPubMed Steinemann DC, Dindo D, Clavien PA, Nocito A (2011) Atraumatic chylous ascites: systematic review on symptoms and causes. J Am Coll Surg 212:899–905CrossRefPubMed
3.
Zurück zum Zitat Falcone EL, Alam A, Tangri N (2008) Mycobacterium avium complex-associated peritonitis in a patient on continuous ambulatory peritoneal dialysis. Clin Nephrol 69:387–390CrossRefPubMed Falcone EL, Alam A, Tangri N (2008) Mycobacterium avium complex-associated peritonitis in a patient on continuous ambulatory peritoneal dialysis. Clin Nephrol 69:387–390CrossRefPubMed
4.
Zurück zum Zitat Koeppe J, Belknap R, Bessesen M (2004) Mycobacterium avium complex peritonitis in the setting of cirrhosis: case report and review of the literature. Scand J Infect Dis 36:615–617CrossRefPubMed Koeppe J, Belknap R, Bessesen M (2004) Mycobacterium avium complex peritonitis in the setting of cirrhosis: case report and review of the literature. Scand J Infect Dis 36:615–617CrossRefPubMed
5.
Zurück zum Zitat Shima K, Sakagami T, Tanabe Y et al (2014) Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients. J Infect Chemother 20:52–56CrossRefPubMed Shima K, Sakagami T, Tanabe Y et al (2014) Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients. J Infect Chemother 20:52–56CrossRefPubMed
6.
Zurück zum Zitat Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F et al (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367–416CrossRefPubMed Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F et al (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367–416CrossRefPubMed
7.
Zurück zum Zitat Song Y, Wu J, Yan H, Chen J (2012) Peritoneal dialysis-associated nontuberculous mycobacterium peritonitis: a systematic review of reported cases. Nephrol Dial Transplant 27:1639–1644CrossRefPubMed Song Y, Wu J, Yan H, Chen J (2012) Peritoneal dialysis-associated nontuberculous mycobacterium peritonitis: a systematic review of reported cases. Nephrol Dial Transplant 27:1639–1644CrossRefPubMed
8.
Zurück zum Zitat Hod T, Kushnir R, Paitan Y, Korzets Z (2008) Mycobacterium fortuitum infection in continuous ambulatory peritoneal dialysis. Clin Nephrol 70:546–553CrossRefPubMed Hod T, Kushnir R, Paitan Y, Korzets Z (2008) Mycobacterium fortuitum infection in continuous ambulatory peritoneal dialysis. Clin Nephrol 70:546–553CrossRefPubMed
9.
Zurück zum Zitat Shu CC, Wang JT, Wang JY, Yu CJ, Lee LN, TAMI Group (2012) Mycobacterial peritonitis: difference between non-tuberculous mycobacteria and Mycobacterium tuberculosis. Clin Microbiol Infect 18:246–252CrossRefPubMed Shu CC, Wang JT, Wang JY, Yu CJ, Lee LN, TAMI Group (2012) Mycobacterial peritonitis: difference between non-tuberculous mycobacteria and Mycobacterium tuberculosis. Clin Microbiol Infect 18:246–252CrossRefPubMed
10.
Zurück zum Zitat Wu UI, Chen MY, Hu RH,et al (2009) Peritonitis due to Mycobacterium avium complex in patients with AIDS: report of five cases and review of the literature. Int J Infect Dis 13:285–290CrossRefPubMed Wu UI, Chen MY, Hu RH,et al (2009) Peritonitis due to Mycobacterium avium complex in patients with AIDS: report of five cases and review of the literature. Int J Infect Dis 13:285–290CrossRefPubMed
11.
Zurück zum Zitat Holland SM, Eisenstein EM, Kuhns DB et al (1994) Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N Engl J Med 330:1348–1355CrossRefPubMed Holland SM, Eisenstein EM, Kuhns DB et al (1994) Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N Engl J Med 330:1348–1355CrossRefPubMed
12.
Zurück zum Zitat Bustamante J, Boisson-Dupuisa S, Abela L, Casanova JL (2014) Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Semin Immunol 26:454–470CrossRefPubMedPubMedCentral Bustamante J, Boisson-Dupuisa S, Abela L, Casanova JL (2014) Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Semin Immunol 26:454–470CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Baerlecken N, Jacobs R, Stoll M, Schmidt RE, Witte T (2009) Recurrent, multifocal Mycobacterium avium-intercellular infection in a patient with interferon-gamma autoantibody. Clin Infect Dis 49:e76–e78CrossRefPubMed Baerlecken N, Jacobs R, Stoll M, Schmidt RE, Witte T (2009) Recurrent, multifocal Mycobacterium avium-intercellular infection in a patient with interferon-gamma autoantibody. Clin Infect Dis 49:e76–e78CrossRefPubMed
15.
Zurück zum Zitat Lin CH, Chi CY, Shih HP et al (2016) Identification of a major epitope by anti-interferon-γ autoantibodies in patients with mycobacterial disease. Nat Med 22:994–1001CrossRefPubMed Lin CH, Chi CY, Shih HP et al (2016) Identification of a major epitope by anti-interferon-γ autoantibodies in patients with mycobacterial disease. Nat Med 22:994–1001CrossRefPubMed
16.
Zurück zum Zitat de Leval L, Gisselbrecht C, Gaulard P (2010) Advances in the understanding and management of angioimmunoblastic T-cell lymphoma. Br J Haematol 148:673–689CrossRefPubMed de Leval L, Gisselbrecht C, Gaulard P (2010) Advances in the understanding and management of angioimmunoblastic T-cell lymphoma. Br J Haematol 148:673–689CrossRefPubMed
17.
Zurück zum Zitat Browne SK, Zaman R, Sampaio EP et al (2012) Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection. Blood 119:3933–3939CrossRefPubMedPubMedCentral Browne SK, Zaman R, Sampaio EP et al (2012) Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection. Blood 119:3933–3939CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Koizumi Y, Sakagami T, Nishiyama N et al (2017) Rituximab restores IFN-γ-STAT1 function and ameliorates disseminated Mycobacterium avium infection in a patient with anti-interferon-γ autoantibody. J Clin Immunol 37:644–649CrossRefPubMed Koizumi Y, Sakagami T, Nishiyama N et al (2017) Rituximab restores IFN-γ-STAT1 function and ameliorates disseminated Mycobacterium avium infection in a patient with anti-interferon-γ autoantibody. J Clin Immunol 37:644–649CrossRefPubMed
Metadaten
Titel
Chylous ascites, anti-interferon-gamma autoantibody, and angioimmunoblastic T-cell lymphoma: a rare but intriguing connection over Mycobacterium avium
verfasst von
Yusuke Koizumi
Takuro Sakagami
Hitoshi Minamiguchi
Aya Makino
Ami Aoki
Keiko Hodohara
Hiroshige Mikamo
Akira Andoh
Yoshihide Fujiyama
Publikationsdatum
06.08.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Medical Microbiology and Immunology / Ausgabe 1/2019
Print ISSN: 0300-8584
Elektronische ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-018-0555-0

Weitere Artikel der Ausgabe 1/2019

Medical Microbiology and Immunology 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.